Clinical trial
Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer
NCT01787331
Study timeline
Study start (actual)2013-10-29Date precision: day
Registry last updated2020-02-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Prostate Adenocarcinomaunresolved
Recurrent Prostate Carcinomaunresolved
Stage I Prostate Adenocarcinoma AJCC v7unresolved
Stage II Prostate Adenocarcinoma AJCC v7unresolved
Interventions
ItraconazoleDRUG · verified · RxNorm: itraconazole
Sponsors & collaborators
University of California, San Franciscolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01787331 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.